Jeeyun Lee


Ontology type: schema:Person     


Person Info

NAME

Jeeyun

SURNAME

Lee

Publications in SciGraph latest 50 shown

  • 2022-04-16 ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2022-04-04 Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2022-01-06 Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial in GENOME MEDICINE
  • 2022-01-03 A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology in MOLECULAR CANCER
  • 2021-09-12 The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2021-09-05 ASO Video Abstract: Microsatellite Instability and the Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer—A Multi-cohort Study in ANNALS OF SURGICAL ONCOLOGY
  • 2021-08-16 Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study in ANNALS OF SURGICAL ONCOLOGY
  • 2021-07-16 A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2021-06-13 Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer in EUROPEAN RADIOLOGY
  • 2021-05-05 ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma in NATURE
  • 2021-02-12 Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer in NATURE COMMUNICATIONS
  • 2021-01-25 Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial in GENOME MEDICINE
  • 2020-12-04 Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2020-11-24 Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2020-09-29 Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions in GENOME MEDICINE
  • 2020-09-24 Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors in GASTRIC CANCER
  • 2020-04-20 Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients in TARGETED ONCOLOGY
  • 2020-02-27 Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study in TARGETED ONCOLOGY
  • 2020-02-18 Comprehensive pharmacogenomic characterization of gastric cancer in GENOME MEDICINE
  • 2020-01-09 Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors in BMC OPHTHALMOLOGY
  • 2019-12-19 RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis in SCIENTIFIC REPORTS
  • 2019-12-09 Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study in TARGETED ONCOLOGY
  • 2019-11-04 Acral malignant melanoma; emphasis on the primary metastasis and the usefulness of preoperative ultrasound for sentinel lymph node metastasis in SCIENTIFIC REPORTS
  • 2019-10-25 Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients in SCIENTIFIC REPORTS
  • 2019-10-01 Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab in SCIENTIFIC REPORTS
  • 2019-08-28 PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation in VIRCHOWS ARCHIV
  • 2019-08-26 Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells in MOLECULAR BIOLOGY REPORTS
  • 2019-08-14 Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody in BMC CANCER
  • 2019-07-04 Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue in SCIENTIFIC REPORTS
  • 2019-03-14 Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator in SCIENTIFIC REPORTS
  • 2019-02-04 Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-12-08 Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-11-12 Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line in BMC CANCER
  • 2018-09-27 Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy in NATURE GENETICS
  • 2018-09-17 Computational measurement of tumor immune microenvironment in gastric adenocarcinomas in SCIENTIFIC REPORTS
  • 2018-07-16 Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer in NATURE MEDICINE
  • 2018-06-18 Transcriptional analysis of immune genes in Epstein–Barr virus-associated gastric cancer and association with clinical outcomes in GASTRIC CANCER
  • 2018-03-22 Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis in ANNALS OF SURGICAL ONCOLOGY
  • 2017-06-01 Gastric adenocarcinoma in NATURE REVIEWS DISEASE PRIMERS
  • 2017-04-18 Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma in CLINICAL AND TRANSLATIONAL ONCOLOGY
  • 2017-04-08 Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2017-03-23 Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy in BMC CANCER
  • 2016-11-16 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-08-04 Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry in INVESTIGATIONAL NEW DRUGS
  • 2016-05-27 FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival in MODERN PATHOLOGY
  • 2016-05-14 A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer in MOLECULAR DIAGNOSIS & THERAPY
  • 2016-05-05 A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma in CLINICAL SARCOMA RESEARCH
  • 2016-03-16 Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin) in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2016-02-18 The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis in BMC CANCER
  • 2016-02-08 Novel strategy for a bispecific antibody: induction of dual target internalization and degradation in ONCOGENE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.414964.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5342.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412091.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.256753.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.255166.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415562.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411653.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15444.30", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412480.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411277.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413046.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26009.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.264381.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411134.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.63984.30", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411947.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413967.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411982.7", 
            "type": "Organization"
          }
        ], 
        "familyName": "Lee", 
        "givenName": "Jeeyun", 
        "id": "sg:person.010115762124.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010115762124.00"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-05-20T08:04", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/person/person_642.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.010115762124.00'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.010115762124.00'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.010115762124.00'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.010115762124.00'


     

    This table displays all metadata directly associated to this object as RDF triples.

    52 TRIPLES      10 PREDICATES      29 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.010115762124.00 schema:affiliation N3adeda4194c0407fb518336cafdfa998
    2 grid-institutes:grid.15444.30
    3 grid-institutes:grid.255166.3
    4 grid-institutes:grid.256753.0
    5 grid-institutes:grid.26009.3d
    6 grid-institutes:grid.264381.a
    7 grid-institutes:grid.410914.9
    8 grid-institutes:grid.411134.2
    9 grid-institutes:grid.411277.6
    10 grid-institutes:grid.411653.4
    11 grid-institutes:grid.411947.e
    12 grid-institutes:grid.411982.7
    13 grid-institutes:grid.412091.f
    14 grid-institutes:grid.412480.b
    15 grid-institutes:grid.413046.4
    16 grid-institutes:grid.413967.e
    17 grid-institutes:grid.415562.1
    18 grid-institutes:grid.5342.0
    19 grid-institutes:grid.63984.30
    20 schema:familyName Lee
    21 schema:givenName Jeeyun
    22 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010115762124.00
    23 schema:sdDatePublished 2022-05-20T08:04
    24 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    25 schema:sdPublisher N50d05ba1744d4d25b64e025b9faa436d
    26 sgo:license sg:explorer/license/
    27 sgo:sdDataset persons
    28 rdf:type schema:Person
    29 N3adeda4194c0407fb518336cafdfa998 schema:affiliation grid-institutes:grid.414964.a
    30 sgo:isCurrent true
    31 rdf:type schema:OrganizationRole
    32 N50d05ba1744d4d25b64e025b9faa436d schema:name Springer Nature - SN SciGraph project
    33 rdf:type schema:Organization
    34 grid-institutes:grid.15444.30 schema:Organization
    35 grid-institutes:grid.255166.3 schema:Organization
    36 grid-institutes:grid.256753.0 schema:Organization
    37 grid-institutes:grid.26009.3d schema:Organization
    38 grid-institutes:grid.264381.a schema:Organization
    39 grid-institutes:grid.410914.9 schema:Organization
    40 grid-institutes:grid.411134.2 schema:Organization
    41 grid-institutes:grid.411277.6 schema:Organization
    42 grid-institutes:grid.411653.4 schema:Organization
    43 grid-institutes:grid.411947.e schema:Organization
    44 grid-institutes:grid.411982.7 schema:Organization
    45 grid-institutes:grid.412091.f schema:Organization
    46 grid-institutes:grid.412480.b schema:Organization
    47 grid-institutes:grid.413046.4 schema:Organization
    48 grid-institutes:grid.413967.e schema:Organization
    49 grid-institutes:grid.414964.a schema:Organization
    50 grid-institutes:grid.415562.1 schema:Organization
    51 grid-institutes:grid.5342.0 schema:Organization
    52 grid-institutes:grid.63984.30 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...